Literature DB >> 28777934

Mutations in TRAPPC12 Manifest in Progressive Childhood Encephalopathy and Golgi Dysfunction.

Miroslav P Milev1, Megan E Grout2, Djenann Saint-Dic1, Yong-Han Hank Cheng2, Ian A Glass2, Christopher J Hale3, David S Hanna3, Michael O Dorschner3, Keshika Prematilake1, Avraham Shaag4, Orly Elpeleg4, Michael Sacher5, Dan Doherty6, Simon Edvardson7.   

Abstract

Progressive childhood encephalopathy is an etiologically heterogeneous condition characterized by progressive central nervous system dysfunction in association with a broad range of morbidity and mortality. The causes of encephalopathy can be either non-genetic or genetic. Identifying the genetic causes and dissecting the underlying mechanisms are critical to understanding brain development and improving treatments. Here, we report that variants in TRAPPC12 result in progressive childhood encephalopathy. Three individuals from two unrelated families have either a homozygous deleterious variant (c.145delG [p.Glu49Argfs∗14]) or compound-heterozygous variants (c.360dupC [p.Glu121Argfs∗7] and c.1880C>T [p. Ala627Val]). The clinical phenotypes of the three individuals are strikingly similar: severe disability, microcephaly, hearing loss, spasticity, and characteristic brain imaging findings. Fibroblasts derived from all three individuals showed a fragmented Golgi that could be rescued by expression of wild-type TRAPPC12. Protein transport from the endoplasmic reticulum to and through the Golgi was delayed. TRAPPC12 is a member of the TRAPP protein complex, which functions in membrane trafficking. Variants in several other genes encoding members of the TRAPP complex have been associated with overlapping clinical presentations, indicating shared and distinct functions for each complex member. Detailed understanding of the TRAPP-opathies will illuminate the role of membrane protein transport in human disease.
Copyright © 2017 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Golgi; TRAPP; TRAPPC12; brain atrophy; encephalopathy; potocerebellar hypoplasia

Mesh:

Substances:

Year:  2017        PMID: 28777934      PMCID: PMC5544387          DOI: 10.1016/j.ajhg.2017.07.006

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Synchronization of secretory protein traffic in populations of cells.

Authors:  Gaelle Boncompain; Severine Divoux; Nelly Gareil; Helene de Forges; Aurianne Lescure; Lynda Latreche; Valentina Mercanti; Florence Jollivet; Graça Raposo; Franck Perez
Journal:  Nat Methods       Date:  2012-03-11       Impact factor: 28.547

2.  Visualization of ER-to-Golgi transport in living cells reveals a sequential mode of action for COPII and COPI.

Authors:  S J Scales; R Pepperkok; T E Kreis
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

3.  A novel TRAPPC11 mutation in two Turkish families associated with cerebral atrophy, global retardation, scoliosis, achalasia and alacrima.

Authors:  Katrin Koehler; Miroslav P Milev; Keshika Prematilake; Felix Reschke; Susann Kutzner; Ramona Jühlen; Dana Landgraf; Eda Utine; Filiz Hazan; Gulden Diniz; Markus Schuelke; Angela Huebner; Michael Sacher
Journal:  J Med Genet       Date:  2016-10-05       Impact factor: 6.318

4.  Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular dystrophy and myopathy with movement disorder and intellectual disability.

Authors:  Nina Bögershausen; Nassim Shahrzad; Jessica X Chong; Jürgen-Christoph von Kleist-Retzow; Daniela Stanga; Yun Li; Francois P Bernier; Catrina M Loucks; Radu Wirth; Eric G Puffenberger; Robert A Hegele; Julia Schreml; Gabriel Lapointe; Katharina Keupp; Christopher L Brett; Rebecca Anderson; Andreas Hahn; A Micheil Innes; Oksana Suchowersky; Marilyn B Mets; Gudrun Nürnberg; D Ross McLeod; Holger Thiele; Darrel Waggoner; Janine Altmüller; Kym M Boycott; Benedikt Schoser; Peter Nürnberg; Carole Ober; Raoul Heller; Jillian S Parboosingh; Bernd Wollnik; Michael Sacher; Ryan E Lamont
Journal:  Am J Hum Genet       Date:  2013-07-03       Impact factor: 11.025

5.  Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda.

Authors:  A K Gedeon; A Colley; R Jamieson; E M Thompson; J Rogers; D Sillence; G E Tiller; J C Mulley; J Gécz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

6.  Trs85 (Gsg1), a component of the TRAPP complexes, is required for the organization of the preautophagosomal structure during selective autophagy via the Cvt pathway.

Authors:  Khuyen Meiling-Wesse; Ulrike D Epple; Roswitha Krick; Henning Barth; Anika Appelles; Christiane Voss; Eeva-Liisa Eskelinen; Michael Thumm
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

7.  C4orf41 and TTC-15 are mammalian TRAPP components with a role at an early stage in ER-to-Golgi trafficking.

Authors:  P James Scrivens; Baraa Noueihed; Nassim Shahrzad; Sokunthear Hul; Stephanie Brunet; Michael Sacher
Journal:  Mol Biol Cell       Date:  2011-04-27       Impact factor: 4.138

8.  TBC1D14 regulates autophagy via the TRAPP complex and ATG9 traffic.

Authors:  Christopher A Lamb; Stefanie Nühlen; Delphine Judith; David Frith; Ambrosius P Snijders; Christian Behrends; Sharon A Tooze
Journal:  EMBO J       Date:  2015-12-28       Impact factor: 11.598

Review 9.  TRAPP Complexes in Secretion and Autophagy.

Authors:  Jane J Kim; Zhanna Lipatova; Nava Segev
Journal:  Front Cell Dev Biol       Date:  2016-03-30

10.  Editorial: Golgi Pathology in Neurodegenerative Diseases.

Authors:  Catherine Rabouille; Georg Haase
Journal:  Front Neurosci       Date:  2016-01-06       Impact factor: 4.677

View more
  12 in total

1.  The TRAPP complex mediates secretion arrest induced by stress granule assembly.

Authors:  Francesca Zappa; Cathal Wilson; Giuseppe Di Tullio; Michele Santoro; Piero Pucci; Maria Monti; Davide D'Amico; Sandra Pisonero-Vaquero; Rossella De Cegli; Alessia Romano; Moin A Saleem; Elena Polishchuk; Mario Failli; Laura Giaquinto; Maria Antonietta De Matteis
Journal:  EMBO J       Date:  2019-08-20       Impact factor: 11.598

2.  A Genome-wide ER-phagy Screen Highlights Key Roles of Mitochondrial Metabolism and ER-Resident UFMylation.

Authors:  Jin Rui Liang; Emily Lingeman; Thao Luong; Saba Ahmed; Matthias Muhar; Truc Nguyen; James A Olzmann; Jacob E Corn
Journal:  Cell       Date:  2020-03-10       Impact factor: 41.582

3.  Impaired XK recycling for importing manganese underlies striatal vulnerability in Huntington's disease.

Authors:  Gaurav Chhetri; Yuting Ke; Ping Wang; Muhammad Usman; Yan Li; Ellen Sapp; Jing Wang; Arabinda Ghosh; Md Ariful Islam; Xiaolong Wang; Adel Boudi; Marian DiFiglia; Xueyi Li
Journal:  J Cell Biol       Date:  2022-09-13       Impact factor: 8.077

4.  Trappc9 deficiency in mice impairs learning and memory by causing imbalance of dopamine D1 and D2 neurons.

Authors:  Yuting Ke; Meiqian Weng; Gaurav Chhetri; Muhammad Usman; Yan Li; Qing Yu; Yingzhuo Ding; Zejian Wang; Xiaolong Wang; Pinky Sultana; Marian DiFiglia; Xueyi Li
Journal:  Sci Adv       Date:  2020-11-18       Impact factor: 14.136

5.  Deficiencies in vesicular transport mediated by TRAPPC4 are associated with severe syndromic intellectual disability.

Authors:  Nicole J Van Bergen; Yiran Guo; Noraldin Al-Deri; Zhanna Lipatova; Daniela Stanga; Sarah Zhao; Rakhilya Murtazina; Valeriya Gyurkovska; Davut Pehlivan; Tadahiro Mitani; Alper Gezdirici; Jayne Antony; Felicity Collins; Mary J H Willis; Zeynep H Coban Akdemir; Pengfei Liu; Jaya Punetha; Jill V Hunter; Shalini N Jhangiani; Jawid M Fatih; Jill A Rosenfeld; Jennifer E Posey; Richard A Gibbs; Ender Karaca; Sean Massey; Thisara G Ranasinghe; Patrick Sleiman; Chris Troedson; James R Lupski; Michael Sacher; Nava Segev; Hakon Hakonarson; John Christodoulou
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

6.  Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein.

Authors:  Miroslav P Milev; Daniela Stanga; Anne Schänzer; Andrés Nascimento; Djenann Saint-Dic; Carlos Ortez; Daniel Natera-de Benito; Desiré González Barrios; Jaume Colomer; Carmen Badosa; Cristina Jou; Pia Gallano; Lidia Gonzalez-Quereda; Ana Töpf; Katherine Johnson; Volker Straub; Andreas Hahn; Michael Sacher; Cecilia Jimenez-Mallebrera
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

Review 7.  Membrane trafficking in health and disease.

Authors:  Rebecca Yarwood; John Hellicar; Philip G Woodman; Martin Lowe
Journal:  Dis Model Mech       Date:  2020-04-30       Impact factor: 5.758

Review 8.  ER-to-Golgi Trafficking and Its Implication in Neurological Diseases.

Authors:  Bo Wang; Katherine R Stanford; Mondira Kundu
Journal:  Cells       Date:  2020-02-11       Impact factor: 6.600

9.  The substrate specificity of the human TRAPPII complex's Rab-guanine nucleotide exchange factor activity.

Authors:  Meredith L Jenkins; Noah J Harris; Udit Dalwadi; Kaelin D Fleming; Daniel S Ziemianowicz; Atefeh Rafiei; Emily M Martin; David C Schriemer; Calvin K Yip; John E Burke
Journal:  Commun Biol       Date:  2020-12-04

Review 10.  Emerging role of NIK/IKK2-binding protein (NIBP)/trafficking protein particle complex 9 (TRAPPC9) in nervous system diseases.

Authors:  Brittany Bodnar; Arianna DeGruttola; Yuanjun Zhu; Yuan Lin; Yonggang Zhang; Xianming Mo; Wenhui Hu
Journal:  Transl Res       Date:  2020-05-17       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.